Will a mAb-Based Immunotherapy Directed Against Cancer Stem Cells Be Feasible?
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.01509
Full Text
Open PDFAbstract
Available in full text
Date
November 9, 2017
Authors
Publisher
Frontiers Media SA